NasdaqGM - Delayed Quote USD
Vera Therapeutics, Inc. (VERA)
At close: October 21 at 4:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 114,497 | 6 |
Sales | 162,104 | 8 |
Net Shares Purchased (Sold) | -47,607 | 14 |
Total Insider Shares Held | 4.29M | -- |
% Net Shares Purchased (Sold) | -1.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
FORDYCE MARSHALL Chief Executive Officer | Sale at price 38.08 - 38.83 per share. | Direct | 597,568 | Oct 9, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Oct 9, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Sale at price 45.42 - 47.06 per share. | Direct | 1,064,809 | Sep 25, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 66,988 | Sep 25, 2024 |
SEIDENBERG BETH C Director | Sale at price 42.00 - 42.31 per share. | Indirect | 696,233 | Sep 19, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Sale at price 37.31 - 37.78 per share. | Direct | 585,934 | Sep 11, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Sep 11, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Sale at price 36.80 - 37.54 per share. | Direct | 1,117,140 | Aug 28, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Aug 28, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Sale at price 39.76 per share. | Direct | 575,425 | Aug 21, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Sale at price 37.56 per share. | Direct | 586,927 | Aug 14, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Aug 14, 2024 |
YOUNG JOSEPH R Officer | Sale at price 42.17 - 43.03 per share. | Direct | 1,304,435 | May 16, 2024 |
YOUNG JOSEPH R Officer | Conversion of Exercise of derivative security at price 3.94 - 7.87 per share. | Direct | 194,911 | May 16, 2024 |
YOUNG JOSEPH R Officer | Sale at price 40.00 per share. | Direct | 228,560 | Apr 10, 2024 |
GRANT SEAN Chief Financial Officer | Sale at price 38.12 - 40.06 per share. | Indirect | 4,689,722 | Apr 3, 2024 |
GRANT SEAN Chief Financial Officer | Conversion of Exercise of derivative security at price 14.87 per share. | Direct | 1,484,442 | Apr 3, 2024 |
KATABI MAHA Director | Sale at price 40.50 - 46.18 per share. | Indirect | 34,099,583 | Mar 25, 2024 |
KATABI MAHA Director | Purchase at price 31.00 per share. | Indirect | 4,999,990 | Jan 30, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
YOUNG JOSEPH R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
GRANT SEAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
COMMODORE CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 18.00 per share. | Indirect | 18,900,000 | Jan 10, 2024 |
FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.32 - 2.90 per share. | Direct | 38,854 | Dec 29, 2023 |
GRANT SEAN Chief Financial Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Dec 20, 2023 |
CURLEY JOANNE Officer | Sale at price 16.66 per share. | Direct | 24,817 | Aug 21, 2023 |
FORDYCE MARSHALL Chief Executive Officer | Sale at price 16.66 per share. | Direct | 86,779 | Aug 21, 2023 |
LIN CELIA Officer | Sale at price 16.65 per share. | Direct | 24,816 | Aug 21, 2023 |
YOUNG JOSEPH R Officer | Conversion of Exercise of derivative security at price 3.94 per share. | Direct | 39,396 | Jul 5, 2023 |
GRANT SEAN Chief Financial Officer | Purchase at price 16.60 per share. | Indirect | 83,000 | Jun 23, 2023 |
COMMODORE CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Purchase at price 15.17 per share. | Indirect | 6,799,004 | Jun 20, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.24 per share. | Indirect | 16,651 | Mar 30, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.24 per share. | Indirect | 173,192 | Mar 28, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.24 per share. | Indirect | 25,102 | Mar 27, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.12 - 7.21 per share. | Indirect | 636,915 | Mar 20, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.09 - 7.12 per share. | Indirect | 660,278 | Mar 16, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.16 per share. | Indirect | 343,485 | Mar 10, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.24 per share. | Indirect | 7,245 | Mar 3, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.24 - 7.25 per share. | Indirect | 170,047 | Mar 2, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.24 per share. | Indirect | 1,447 | Feb 23, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.20 per share. | Indirect | 72,490 | Feb 13, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.25 per share. | Indirect | 2,900 | Feb 9, 2023 |
SEIDENBERG BETH C Director | Purchase at price 7.03 - 7.24 per share. | Indirect | 2,209,588 | Feb 8, 2023 |
ENRIGHT PATRICK G. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.00 per share. | Indirect | 11,999,995 | Feb 6, 2023 |
SOFINNOVA VENTURE PARTNERS X, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.00 per share. | Direct | 1,999,998 | Feb 6, 2023 |
LONGITUDE CAPITAL PARTNERS IV, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.00 per share. | Indirect | 11,999,995 | Feb 6, 2023 |
YOUNG JOSEPH R Officer | Purchase at price 7.00 per share. | Direct | 39,998 | Feb 6, 2023 |
GRANT SEAN Officer | Purchase at price 7.00 per share. | Direct | 99,995 | Feb 6, 2023 |
CURLEY JOANNE Officer | Sale at price 19.12 - 20.17 per share. | Direct | 43,116 | Dec 16, 2022 |
CURLEY JOANNE Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 6,408 | Dec 16, 2022 |
Related Tickers
JANX Janux Therapeutics, Inc.
50.49
+0.92%
EWTX Edgewise Therapeutics, Inc.
34.85
-2.02%
APGE Apogee Therapeutics, Inc.
52.97
-1.05%
DYN Dyne Therapeutics, Inc.
33.48
-4.99%
PTGX Protagonist Therapeutics, Inc.
45.96
-2.15%
KYMR Kymera Therapeutics, Inc.
46.56
+0.32%
AGIO Agios Pharmaceuticals, Inc.
45.66
+0.35%
RNA Avidity Biosciences, Inc.
46.71
-7.41%
SLNO Soleno Therapeutics, Inc.
53.75
-0.76%
ACLX Arcellx, Inc.
90.28
-6.79%